306 filings
Page 4 of 16
8-K/A
SBFM
Sunshine Biopharma Inc
12 Dec 22
Financial Statements and Exhibits
4:31pm
8-K
SBFM
Sunshine Biopharma Inc
9 Dec 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
4
Sebaaly Camille
2 Dec 22
Sunshine Biopharma / Camille Sebaaly ownership change
6:01am
10-Q
2022 Q3
SBFM
Sunshine Biopharma Inc
Quarterly report
7 Nov 22
7:30am
SC 13G
Malek Chamoun
2 Nov 22
Sunshine Biopharma / Chamoun Malek ownership change
11:13am
3
Malek Chamoun
26 Oct 22
Sunshine Biopharma / Malek Chamoun ownership change
3:39pm
8-K
SBFM
Sunshine Biopharma Inc
20 Oct 22
Sunshine Biopharma ANNOUNCES THE ACQUISITION OF NORA PHARMA, ADDING $10.7 MILLION IN REVENUE
7:30am
10-Q
2022 Q2
SBFM
Sunshine Biopharma Inc
Quarterly report
3 Aug 22
4:43pm
4
Sebaaly Camille
6 Jun 22
Sunshine Biopharma / Camille Sebaaly ownership change
12:36pm
EFFECT
SBFM
Sunshine Biopharma Inc
23 May 22
Notice of effectiveness
12:15am
424B3
SBFM
Sunshine Biopharma Inc
20 May 22
Prospectus supplement
4:59pm
CORRESP
SBFM
Sunshine Biopharma Inc
18 May 22
Correspondence with SEC
12:00am
UPLOAD
SBFM
Sunshine Biopharma Inc
18 May 22
Letter from SEC
12:00am
S-3
SBFM
Sunshine Biopharma Inc
Shelf registration
10 May 22
4:31pm
10-Q
2022 Q1
SBFM
Sunshine Biopharma Inc
Quarterly report
6 May 22
2:47pm
D
SBFM
Sunshine Biopharma Inc
29 Apr 22
$19.5M in equity / options, sold $19.5M, 9 investors
2:13pm
8-K
SBFM
Sunshine Biopharma Inc
28 Apr 22
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
5:03pm
EFFECT
SBFM
Sunshine Biopharma Inc
11 Apr 22
Notice of effectiveness
12:15am
8-K
SBFM
Sunshine Biopharma Inc
8 Apr 22
Departure of Directors or Certain Officers
4:05pm
424B3
SBFM
Sunshine Biopharma Inc
8 Apr 22
Prospectus supplement
9:10am